Myths vs facts: IgE and Schlaf

The question of myths vs. facts about IgE and sleep touches on a complex interplay between the immune system and circadian rhythms. IgE (immunoglobulin E) is primarily involved in allergic reactions – it binds to mast cells and, upon allergen contact, releases histamine and other inflammatory mediators. A common myth is that IgE directly disrupts sleep. In reality, it is not IgE itself but the allergic inflammation (e.g., in allergic rhinitis, asthma, or atopic dermatitis) that impairs sleep quality through symptoms like itching, coughing, or nasal congestion. Studies show that individuals with elevated total IgE or specific IgE report more sleep disturbances, but the effect is moderate and highly dependent on individual allergen exposure and comorbidities. Another myth: a normal IgE level rules out sleep-related allergies. This is false, as local IgE production in the nasal mucosa can occur without systemic elevation („entopy“). Fact: sleep deprivation itself can influence IgE production – chronic sleep loss shifts cytokine profiles toward Th2 responses, potentially worsening allergies. The evidence base is predominantly human-observational and mechanistic. For individual assessment, allergy tests (prick, specific IgE) and a sleep diary are more informative than a single IgE blood value. Caveat: DTC tests for IgE often lack clinically actionable information regarding sleep quality.